** Citi Forecasts Hls to Distribute Special Dividend of 40 Australian Cents/Share From Sale of LumusRemoves Extraneous Refinitiv Instrument Code
移除多餘的Refinitiv工具代碼
** Citi Upgrades Healius' Hls.ax Rating to "Neutral" From "Sell" on Recent Share Price Decline, The Sale of Co's Unit Lumus Imaging and Cost Base of Its Pathology Segment Reflecting Its True Business as Usual Costs
** 花旗將Healius的評級提高至『中立』 Hls.ax 評級從『賣出』調整爲『中立』，原因是最近股價下降， 公司旗下子公司Lumus Imaging的出售 以及其病理部門的成本基礎反映了其真實的業務常規成本
** Brokerage Trims Price Target for Co to a$1.05 From a$1.5 to Reflect Lumus Sale in Its Forecasts
** 券商將公司的目標價從a$1.5下調至a$1.05，以反映Lumus銷售在其預測中的影響
** Citi Forecasts Hls to Distribute Special Dividend of 40 Australian Cents/Share From Sale of Lumus
**花旗預測Hls將通過出售Lumus分發每股40澳元的特別股息
** the Aussie Healthcare Firm on Friday Shared Positive Outlook for Its Pathology Business, Foreacsting Strong Growth in 2H
**這家澳洲醫療保健公司在週五 共享 對其病理業務持積極展望，預計下半年將實現強勁增長
** Hls Down ~19.9% YTD as of Last Close, Underperforming Against a 3.4% Gain on the ASX Health Care Index .axhj
**截至最後收盤，Hls年初至今下跌約19.9%，表現不及ASX醫療保健指數的3.4%的漲幅 .axhj
($1 = 1.5319 Australian Dollars)
（1美元 = 1.5319澳元）
(Reporting by Nikita Maria Jino in Bengaluru)
（由尼基塔·瑪利亞·吉諾在班加羅爾報道）
((Nikita.jino@Thomsonreuters.com))
((Nikita.jino@Thomsonreuters.com))
